Our hypothesis, if proves true, raises an interesting perspective on targeting the TRPM2 channel as a preventative and therapeutic strategy to limit the risk of PM2.5 exposure to AD and age-related brain damage in humans. This evidence concerns the gene TRPM2 and Alzheimer disease.